Edible Garden AG Inc — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Edible Garden AG Inc filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.81M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $13.86M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $14.05M | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | $11.55M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $10.51M | Mar 22, 2023 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($204.0K) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $2.31M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $822.0K | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | $364.0K | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $648.0K | Mar 22, 2023 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($17.33M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($11.05M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($10.19M) | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | ($12.45M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($5.54M) | Mar 22, 2023 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($15.80M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($9.28M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($9.87M) | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | ($9.00M) | Apr 1, 2024 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.60M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $11.59M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $10.01M | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | $9.37M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $5.61M | Mar 22, 2023 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($11.80M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($8.52M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($8.53M) | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | ($9.19M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($4.08M) | Mar 22, 2023 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $638.0K | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $303.0K | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $1.02M | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | $1.98M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $151.0K | Mar 22, 2023 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $20.60M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $11.92M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $6.66M | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | $6.97M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $3.99M | Mar 22, 2023 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.10M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $7.82M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | $6.94M | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | $9.15M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $11.10M | Mar 22, 2023 |
| FY2022 | Nov 29, 2021 | $79.0K | Mar 22, 2023 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.50M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $4.09M | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | ($288.0K) | Mar 31, 2026 |
| FY2024 | Dec 31, 2022 | ($2.18M) | Apr 1, 2025 |
| FY2023 | Dec 31, 2021 | ($7.11M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2020 | ($2.08M) | Mar 22, 2023 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($58.64M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($41.31M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($30.26M) | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | ($20.07M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($7.62M) | Mar 22, 2023 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $110.0K | Mar 22, 2023 |
| FY2022 | Dec 31, 2021 | $31.0K | Mar 22, 2023 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.66M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | $2.48M | Mar 31, 2026 |
| FY2022 | Dec 31, 2022 | $4.28M | Mar 22, 2023 |
| FY2022 | Dec 31, 2021 | $3.88M | Mar 22, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (117) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | (685) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | (1,541) | Apr 1, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 593,423 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 106,540 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 11,411 | Apr 1, 2025 |
| FY2023 | Dec 31, 2022 | 362,716 | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 166,667 | Mar 22, 2023 |